Custodianship as an Ethical Framework for Biospecimen-Based Research

被引:38
作者
Yassin, Rihab [1 ]
Lockhart, Nicole [2 ]
del Riego, Mariana Gonzalez [6 ]
Pitt, Karen [3 ]
Thomas, Jeffrey W. [4 ]
Weiss, Linda [5 ]
Compton, Carolyn [2 ]
机构
[1] NCI, Div Canc Biol, Bethesda, MD 20892 USA
[2] NCI, Off Biorepositories & Biospecimen Res, Bethesda, MD 20892 USA
[3] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA
[4] NCI, Technol Transfer Ctr, Bethesda, MD 20892 USA
[5] NCI, Off Canc Ctr, Bethesda, MD 20892 USA
[6] Sci Applicat Int Corp Frederick Inc, Rose Li & Associates Inc, NCI Frederick, Frederick, MD USA
关键词
OWNERSHIP;
D O I
10.1158/1055-9965.EPI-10-0029
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human biological specimens (biospecimens) are increasingly important for research that aims to advance human health. Yet, despite significant proliferation in specimen- based research and discoveries during the past decade, research remains challenged by the inequitable access to high- quality biospecimens that are collected under rigorous ethical standards. This is primarily caused by the complex level of control and ownership exerted by the myriad of stakeholders involved in the biospecimen research process. This article discusses the ethical model of custodianship as a framework for biospecimen- based research to promote fair research access and resolve issues of control and potential conflicts between biobanks, investigators, human research participants (human subjects), and sponsors. Custodianship is the caretaking obligation for biospecimens frominitial collection to final dissemination of research findings. It endorses key practices and operating principles for responsible oversight of biospecimens collected for research. Embracing the custodial model would ensure transparency in research, fairness to human research participants, and shared accountability among all stakeholders involved in biospecimen- based research. Cancer Epidemiol Biomarkers Prev; 19(4); 1012-5. (C)2010 AACR.
引用
收藏
页码:1012 / 1015
页数:4
相关论文
共 13 条
[1]  
[Anonymous], 2007, BEST PRACT BIOSP RES
[2]  
[Anonymous], Financial Conflict of Interest | grants.nih.gov
[3]  
AURAYBLAIS C, 2006, BMC MED ETHICS, V7, P1
[4]   An 'Honest Broker' mechanism to maintain privacy for patient care and academic medical research [J].
Boyd, Andrew D. ;
Hosner, Charlie ;
Hunscher, Dale A. ;
Athey, Brian D. ;
Clauw, Daniel J. ;
Green, Lee A. .
INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2007, 76 (5-6) :407-411
[5]   Body of research - Ownership and use of human tissue [J].
Charo, R. Alta .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (15) :1517-1519
[6]  
Dressler L, 2005, HUMAN SPECIMENS CANC
[7]   Biospecimen "ownership": Counterpoint [J].
Dressler, Lynn G. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (02) :190-191
[8]  
Eiseman E., 1999, HDB HUMAN TISSUE SOU
[9]  
FRIEDE A, NATL BIOSPECIMEN NET
[10]   Key elements of access policies for biorepositories associated with population science research [J].
Lemrow, Shannon M. ;
Colditz, Graham A. ;
Vaught, Jimmie B. ;
Hartge, Patricia .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (08) :1533-1535